Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention

被引:15
|
作者
Youssef, Ali A.
Wu, Chiung-Jen
Hang, Chi-Ling
Cheng, Cheng-I
Yang, Cheng-Hsu
Chen, Chien-Jen
Chen, Yen-Hsun
Chai, Han-Tan
Chua, Sarah
Yeh, Kuo-Ho
Yip, Hon-Kan
机构
[1] Chang Gung Univ Coll Med, Dept Internal Med, Div Cardiol, Chang Gung Mem Hosp,Kaohsiung Med Ctr, Kaohsiung 83301, Taiwan
[2] Suez Canal Univ Hosp, Dept Cardiol, Ismailia, Egypt
关键词
nitroprusside; no-reflow; PercuSurge device; slow-flow;
D O I
10.1253/circj.70.1538
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The present study tested the hypothesis that when administered in conjunction with a PercuSurge device for treatment of acute myocardial infarction (AMI), intracoronary (IC) administration of nitroprusside (NTP) is safe and superior to IC administration of NTP alone or nitroglycerin (NTG) for reversing slow-flow or no-reflow, both of which occur frequently during primary percutaneous coronary intervention (PCI). Methods and Results Sixty-two patients with ST-segment elevation AMI of < 12h duration undergoing primary PCI were enrolled. When the final Thrombolysis In Myocardial Infarction (TIMI) flow was normal (TIMI-3), NTG 200 mu g was administered first, followed by (5 min later) NTP 100,mu g via an intra-guiding catheter. When final TIMI flow was <= 2, NTG 200 mu g was given, followed by NTP 100 mu g via an export suction catheter advanced into the infract-related artery (IRA). Primary endpoint was epicardial blood flow (TIMI-flow), corrected TIMI frame counts, or microvascular circulation [myocardial blush (MB) grade]. Analytical results indicated that the final TIMI-3 flow was significantly higher in patients receiving NTP than in those receiving NTG therapy (100% vs 88.7%, p=0.023). As compared with NTG, NTP therapy significantly improved final MB grade (p < 0.0001) and corrected TIMI flame count time (p < 0.0001). Subgroup analysis demonstrated that final MB grade (p < 0.001) and corrected TIMI flame count time (p < 0.01) were significantly higher in patients (n=33) with than in patients (n=29) without the PercuSurge. No significant NTP related adverse events occurred, apart from insignificant transient hypotension. Conclusion IC administration of NTP is safe and superior to NTG for improving final epicardial blood flow and microvascular circulation in patients with AMI undergoing primary PCI. Combination therapy of PercuSurge device and NTP provided an additional benefit to NTP alone for improving microvascular circulation.
引用
收藏
页码:1538 / 1542
页数:5
相关论文
共 50 条
  • [41] Association of endothelial dysfunction and no-reflow during primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Levi, Yaniv
    Sultan, Ayyaz
    Alemayehu, Mistre
    Wall, Sabrina
    Lavi, Shahar
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2016, 17 (08) : 552 - 555
  • [42] Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention
    Su, Qiang
    Ye, Ziliang
    Sun, Yuhan
    Yang, Huafeng
    Li, Lang
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (04) : 318 - 324
  • [43] Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
    Aitmokhtar, Omar
    Paganelli, Franck
    Benamara, Saida
    Azaza, Adel
    Bonello, Laurent
    Harnza, Ouafa
    Seddiki, Saber
    Benathmane, Tayeb
    Saidane, Mourad
    Bouzid, Ahmed
    Kara, Maamar
    Sik, Arezki
    Azzouz, Abdelmalek
    Harbi, Faiza
    Monsuez, Jean-Jacques
    Benkhedda, Salim
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2017, 110 (11) : 626 - 633
  • [44] Development and Validation of a Clinical Risk Score Predicting the No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
    Wang, Jin-Wen
    Chen, Yun-Dai
    Wang, Chang-Hua
    Yang, Xin-Chun
    Zhu, Xiao-Ling
    Zhou, Zi-Qiang
    CARDIOLOGY, 2013, 124 (03) : 153 - 160
  • [45] The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention
    Abacioglu, Ozge Ozcan
    Yildirim, Arafat
    Koyunsever, Nermin Yildiz
    Kilic, Salih
    ANGIOLOGY, 2022, 73 (01) : 79 - 84
  • [46] Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention
    Refaat, Hesham
    Tantawy, Ayman
    Gamal, Amr S.
    Radwan, Hanan
    INDIAN HEART JOURNAL, 2021, 73 (01) : 35 - 43
  • [47] Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention
    Pelliccia, Francesco
    Niccoli, Giampaolo
    Zimarino, Marco
    Ando, Giuseppe
    Porto, Italo
    Calabro, Paolo
    De Rosa, Salvatore
    Gragnano, Felice
    Piccolo, Raffaele
    Moscarella, Elisabetta
    Fabris, Enrico
    Montone, Rocco Antonio
    Spaccarotella, Carmen
    Indolfi, Ciro
    Sinagra, Gianfranco
    Filardi, Pasquale Perrone
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (12)
  • [48] Predictive effect of triglyceride-glucose index on No-Reflow Phenomenon in patients with type 2 diabetes mellitus and acute myocardial infarction undergoing primary percutaneous coronary intervention
    Juan Ma
    Mohan Wang
    Peng Wu
    Xueping Ma
    Dapeng Chen
    Shaobin Jia
    Ning Yan
    Diabetology & Metabolic Syndrome, 16
  • [49] Predictive effect of triglyceride-glucose index on No-Reflow Phenomenon in patients with type 2 diabetes mellitus and acute myocardial infarction undergoing primary percutaneous coronary intervention
    Ma, Juan
    Wang, Mohan
    Wu, Peng
    Ma, Xueping
    Chen, Dapeng
    Jia, Shaobin
    Yan, Ning
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01)
  • [50] Vitamin D level predicts angiographic no-reflow phenomenon after percutaneous coronary intervention in patients with ST segment elevation myocardial infarction
    Sen, Omer
    Sen, Sidika B.
    Topuz, Ayse N.
    Topuz, Mustafa
    BIOMARKERS IN MEDICINE, 2021, 15 (15) : 1357 - 1366